No abstract available
MeSH terms
-
Diabetic Angiopathies*
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Myocardial Infarction* / drug therapy
-
Myocardial Infarction* / mortality
-
Myocardial Infarction* / physiopathology
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Factors
-
Treatment Outcome